SLC22A4 and inflammatory bowel disease: We have shown that turmeric and specific fractions of it can: (1) reduce the abnormal transport function of the SLC22A4 503F variant and (2) increase the activity of the IL-10 promoter variant (ACC, −1082 A) that has reduced activity in IBD.